Presentation Information
[F2-22]Mechanism and strategy of monoclonal cross-species reactive IgA treatment for gut microbiota regulation
*Genta Furuya1, Fumihito Usui2, Keishu Takahashi1, Satoru Nagatoishi3, Rae Maeda4, Tomoki Yoshihara5, Ryutaro Tamano1, Tomoya Ohno1, Kengo Sasaki1, Naoki Morita1, Peng Gao1, Fabian Eisenstein6, Hirofumi Kosuge3, Masumi Shirakawa7, Hiroyuki Arai8, Min Fey Chek5, Radostin Danev6, Hirotada Mori9, Masahide Kikkawa6, Shinsuke Sando7, Naoshi Dohmae10, Toshio Hakoshima5, Yuki Sugiura4, Kouhei Tsumoto3, Reiko Shinkura1 (1. Institute for Quantitative Biosciences, The University of Tokyo (Japan), 2. Applied Immunology, Graduate School of Science and Technology, Nara Institute of Science and Technology (Japan), 3. Department of Bioengineering, School of Engineering, The University of Tokyo (Japan), 4. Center for Cancer Immunotherapy and Immunobiology, Kyoto University Graduate School of Medicine (Japan), 5. Division of Biological Science, Graduate School of Science and Technology, Nara Institute of Science and Technology (Japan), 6. Graduate School of Medicine, The University of Tokyo (Japan), 7. Department of Chemistry and Biotechnology, Graduate School of Engineering, The University of Tokyo (Japan), 8. Department of Biotechnology, Graduate School of Agricultural and Life Sciences, The University of Tokyo (Japan), 9. Faculty of Engineering, Shinshu University (Japan), 10. Biomolecular Characterization Unit, RIKEN Center for Sustainable Resource Science (Japan))

Password required to view
Log in
or
Comment
To browse or post comments, you must log in.Log in
